NSCLC STAGE II
Clinical trials for NSCLC STAGE II explained in plain language.
Never miss a new study
Get alerted when new NSCLC STAGE II trials appear
Sign up with your email to follow new studies for NSCLC STAGE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Aiming to spare lung cancer patients from chemo: a smarter Pre-Surgery plan?
Disease control Not yet recruitingThis phase 2 trial tests whether the immunotherapy drug cemiplimab can be used alone before surgery for certain patients with early-stage non-small cell lung cancer (NSCLC) that can be removed. The goal is to see if some patients can safely skip chemotherapy and its harsh side ef…
Matched conditions: NSCLC STAGE II
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New drug combo aims to wipe out lung cancer before surgery
Disease control Not yet recruitingThis study tests a new drug combination (JSKN016, toripalimab, and carboplatin) given before surgery to people with stage II or III non-small cell lung cancer that can be removed. The goal is to see if the treatment can completely or mostly eliminate the tumor before the operatio…
Matched conditions: NSCLC STAGE II
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC